checkAd

     233  0 Kommentare Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

    COPENHAGEN, Denmark, September 1, 2023 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the company’s shares/related securities by persons holding managerial responsibilities and/or persons/companies closely associated with such.

    1. Details of the person discharging managerial responsibilities/person closely associated  
    a) Name Henrik Juuel
    2. Reason for the notification
    a) Position/status Executive Vice President and Chief Financial Officer of Bavarian Nordic A/S
    b) Initial notification/Amendment Initial notification
    3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
    a) Name Bavarian Nordic A/S
    b) LEI 2138006JCDVYIN6INP51
    4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
    a) Description of the financial instrument, type of instrument


    Identification code
    Shares


    DK0015998017
    b) Nature of the transaction Purchase
    c) Price(s) and volume(s) Price(s) Volume(s)
        DKK 149.56 3,375
    d) Aggregated information
    • Aggregated volume
    • Price
     

    3,375
    DKK 504,775.55
    e) Date of the transaction 2023-09-01
    f) Place of the transaction Nasdaq Copenhagen A/S, XCSE

    About Bavarian Nordic
    Bavarian Nordic is a fully integrated vaccines company focused on the research and development, manufacturing and commercialization of life-saving vaccines. We are a global leader in smallpox and mpox vaccines, which have been developed through our long-standing partnership with the U.S. Government to enhance public health preparedness and have a strong portfolio of vaccines for travelers and endemic diseases. For more information visit www.bavarian-nordic.com.

    Contacts
    Europe: Rolf Sass Sørensen, Vice President Investor Relations, Tel: +45 61 77 47 43
    US: Graham Morrell, Paddock Circle Advisors, graham@paddockcircle.com, Tel: +1 781 686 9600

    Company Announcement no. 33 / 2023

    Attachment





    Diskutieren Sie über die enthaltenen Werte



    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such COPENHAGEN, Denmark, September 1, 2023 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the company’s shares/related securities by persons holding managerial responsibilities and/or …